VSEE director granted 40,107-share equity award

WICKERSHAM DAVID L. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/05/2026 - 04:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

WICKERSHAM DAVID L. reported acquisition or exercise transactions in this Form 4 filing.

VSEE HEALTH, INC. director David L. Wickersham reported an equity award of 40,107 shares of common stock on March 4, 2026. The award was issued under the company’s 2024 Incentive Plan as compensation for his services as a non-employee director for the quarter ended December 31, 2025, with the number of shares based on the closing price of the common stock on December 31, 2025.

After this grant, Wickersham directly holds 1,187,671 shares of VSEE common stock.

Insider Trade Summary

Grant/Award: 40,107 shares

Grant/Award 1 txn

Insider WICKERSHAM DAVID L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001 per share	40,107	$0.374	$15K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 1,187,671 shares (Direct)

Holdings Before and After: Common Stock, par value $0.0001 per share, 1,147,564 to 1,187,671 shares (Direct)

Footnotes (1)

1. F1. Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan in accordance with the issuer's non-employee director compensation policy for services as a director during the quarter ended December 31, 2025. The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did VSEE (VSEE) director David L. Wickersham report on this Form 4?

Director David L. Wickersham reported receiving an equity award of 40,107 VSEE HEALTH, INC. common shares. The shares were granted as non-employee director compensation under the company’s 2024 Incentive Plan for the quarter ended December 31, 2025, based on that date’s closing price.

How many VSEE (VSEE) shares were granted to David L. Wickersham and under which plan?

David L. Wickersham was granted 40,107 shares of VSEE common stock. These shares were issued under VSEE HEALTH, INC.’s 2024 Incentive Plan, in line with the non-employee director compensation policy for service during the quarter ended December 31, 2025.

What is David L. Wickersham’s VSEE (VSEE) share ownership after this transaction?

After the reported equity grant, David L. Wickersham directly holds 1,187,671 shares of VSEE HEALTH, INC. common stock. This figure reflects his total direct ownership immediately following the 40,107-share award reported in the Form 4 filing.

Was the VSEE (VSEE) transaction a market purchase or an equity award?

The transaction was an equity award, not a market purchase. VSEE HEALTH, INC. issued 40,107 common shares to David L. Wickersham under its 2024 Incentive Plan as non-employee director compensation for the quarter ended December 31, 2025.

How was the number of VSEE (VSEE) shares in the award determined?

The number of shares in the award was based on the closing price of VSEE common stock on December 31, 2025. Using that closing price, VSEE HEALTH, INC. calculated that 40,107 shares should be issued to David L. Wickersham as director compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WICKERSHAM DAVID L.

(Last) (First) (Middle)

C/O VSEE HEALTH, INC.

980 N FEDERAL HWY #304

(Street)

BOCA RATON FL 33432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VSEE HEALTH, INC. [ VSEE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	03/04/2026		A		40,107	A	$0.374(1)	1,187,671	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan in accordance with the issuer's non-employee director compensation policy for services as a director during the quarter ended December 31, 2025. The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025.

	/s/ David L. Wickersham	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.